Case Studies

Craig I. Coleman, PharmD
Published Online: Wednesday, April 16, 2014
Follow Pharmacy_Times:
Case 1
SC is a 33-year-old woman who comes to your pharmacy’s urgent care clinic complaining of frequent painful urination and flank pain over her kidneys. She denies having fever, chills, nausea, or vomiting, and seems well hydrated. SC has no notable medical history and does not take prescription medications. The nurse at the pharmacy-based clinic performs a urine dipstick urinalysis, which has a positive result for bacteria and pyuria (white blood cells in the urine), and sends out a urine specimen for culture. The nurse makes a diagnosis of pyelonephritis and decides that SC can be treated as an outpatient. The nurse asks the pharmacist for advice regarding an empiric antibiotic regimen to treat SC.
What antibiotic should the pharmacist recommend for empiric therapy in SC?

Case 2
CC, a 38-year-old man, goes to his primary care physician complaining of insomnia. Upon questioning, CC notes that he has been having difficulty falling asleep almost every night for the past 4 weeks, but once he falls asleep, he sleeps through the remainder of the night. As a result of this sleep pattern, CC reports waking up tired and feels that his performance at work is beginning to suffer. CC travels frequently (2 to 3 times per month) and recently had a severe case of viral colitis that he acquired on a trip overseas. The colitis resulted in a 1-week hospital stay a few weeks ago, but the condition has completely resolved. CC has no other significant medical history and takes no prescription medications. His physician would like to use pharmacotherapy to treat the insomnia.
What agent(s) would you recommend to treat CC’s insomnia?

Dr. Coleman is professor of pharmacy practice, as well as codirector and methods-chief at Hartford Hospital Evidence-Based Practice Center, at the University of Connecticut School of Pharmacy.

Related Articles
Research has shown that St. John’s wort could help patients suffering from depression.
The value of a good night’s sleep is often underestimated until one experiences insomnia. Left untreated, insomnia can negatively impact an individual’s health, ability to perform routine tasks, and overall quality of life.
Merck has announced the US launch of its insomnia medication, suvorexant, an orexin receptor antagonist indicated for the treatment of adults who have difficulty falling or staying asleep.
What’s keeping insomniacs awake at night might also be raising their blood pressure.
Latest Issues
  • photo
    Pharmacy Times
    Health-System Edition
    Directions in Pharmacy
    OTC Guide
    Generic Supplements
  • photo
    Pharmacy Careers
    Specialty Pharmacy Times